Maxime Meylan
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 3
-
- Renal cell carcinoma treatment 9
- Ferroptosis and cancer prognosis 5
- Co-authors
- Catherine Sautès‐Fridman (20 shared papers)Wolf H. Fridman (12 shared papers)Florent Petitprez (6 shared papers)Cheng‐Ming Sun (5 shared papers)Aurélien de Reyniès (2 shared papers)Antoîne Italiano (1 shared paper)Tom Wei‐Wu Chen (2 shared papers)Lubka T. Roumenina (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (4 papers)Frontiers in Immunology (3 papers)Clinical Cancer Research (2 papers)Metabolism (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Maxime Meylan
23 papers receiving 1.4k citations
Maxime Meylan's Hit Papers
Peers
Comparison fields: 5 of 80
- Immunology 608
- Oncology 710
- Cancer Research 170
- Pulmonary and Respiratory Medicine 221
- Molecular Biology 336
Countries citing papers authored by Maxime Meylan
This map shows the geographic impact of Maxime Meylan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Meylan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Meylan more than expected).
Fields of papers citing papers by Maxime Meylan
This network shows the impact of papers produced by Maxime Meylan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Meylan. The network helps show where Maxime Meylan may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxime Meylan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies Hit paper breakdown → | 2020 | 419 |
| 2 | B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome Hit paper breakdown → | 2022 | 406 |
| 3 | Tertiary lymphoid structures and B cells: An intratumoral immunity cycle Hit paper breakdown → | 2023 | 157 |
| 4 | 2020 | 142 | |
| 5 | 2020 | 90 | |
| 6 | 2020 | 80 | |
| 7 | 2020 | 62 | |
| 8 | 2021 | 33 | |
| 9 | 1987 | 31 | |
| 10 | 2023 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2021 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2026 | 1 | |
| 20 | 2020 | 1 |
About Maxime Meylan
Maxime Meylan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Molecular Biology, having authored 26 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Renal cell carcinoma treatment (9 papers), Immune Cell Function and Interaction (6 papers), Ferroptosis and cancer prognosis (5 papers), Immunotherapy and Immune Responses (4 papers), Cancer Genomics and Diagnostics (3 papers), Immune cells in cancer (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Immunology (608 citations), Oncology (710 citations), Cancer Research (170 citations), Pulmonary and Respiratory Medicine (221 citations) and Molecular Biology (336 citations). Maxime Meylan has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Catherine Sautès‐Fridman, Wolf H. Fridman, Florent Petitprez, Cheng‐Ming Sun, Aurélien de Reyniès, Antoîne Italiano, Tom Wei‐Wu Chen, Lubka T. Roumenina, Isaias Hernández-Verdín and Anne Calvez. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Frontiers in Immunology, Clinical Cancer Research and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.